Can psoriatic arthritis start in childhood or adolescence? 

Yes, psoriatic arthritis can and does occur in children and adolescents. When it begins before the age of 16, it is classified as juvenile psoriatic arthritis (JPsA), which is a specific subtype of juvenile idiopathic arthritis (JIA). While psoriatic arthritis is more commonly associated with adults between the ages of 30 and 50, it is estimated that approximately 5% of children with JIA have the psoriatic subtype. This condition requires a distinct diagnostic approach because, in many young people, the joint inflammation begins several years before any visible skin psoriasis appears. 

What We’ll Discuss in This Article 

• The typical age of onset for juvenile psoriatic arthritis. 

• The two distinct peaks of onset in childhood and adolescence. 

• Key physical symptoms that distinguish JPsA from other childhood arthritis. 

• The criteria used for diagnosis when a skin rash is not present. 

• The importance of monitoring for eye and nail changes. 

• Current NHS management strategies for young people. 

Two peaks of onset in young people 

Clinical data shows that juvenile psoriatic arthritis typically presents in two distinct age groups, often referred to as “peaks.” These peaks help clinicians understand the likely course of the condition and which symptoms might be most prominent. 

The first peak typically occurs in early childhood, often between the ages of 2 and 3 years. This early onset version is more common in girls and frequently affects the small joints of the hands and feet. The second peak occurs during later childhood or early adolescence, usually between the ages of 10 and 12 years. In this older age group, the condition affects boys and girls more equally and is often associated with inflammation in the spine or the areas where tendons attach to bone. 

Identifying JPsA without a skin rash 

One of the most challenging aspects of juvenile psoriatic arthritis is that in up to 80% of children, the joint symptoms appear before the skin psoriasis. Because of this, UK diagnostic criteria allow for a diagnosis of JPsA even in the absence of a rash, provided the child has arthritis and at least two of the following clinical features: 

• Dactylitis (swelling of an entire finger or toe). 

• Nail pitting or ridges (small dents in the fingernails or toenails). 

• Onycholysis (the nail lifting away from the nail bed). 

• A first-degree relative (parent or sibling) with a confirmed diagnosis of psoriasis.¹² 

If a child has a visible psoriatic rash and joint inflammation, the diagnosis is more straightforward. However, the presence of the other “minor” criteria is essential for early identification in those without skin involvement. 

Comparison of early and late onset JPsA 

The way the condition behaves can vary depending on the age at which it starts. Younger children tend to have a pattern that mirrors other forms of juvenile arthritis, while adolescents often show symptoms that more closely resemble adult psoriatic arthritis.¹³ 

Feature	Early Onset (Ages 2–3)	Late Onset (Ages 10–12)
Gender Prevalence	More common in girls	Equally common in boys and girls
Typical Joints	Small joints (fingers/toes)	Large joints and the spine
Tendon Involvement	Less common	Frequent (Enthesitis)
Common Symptom	Dactylitis (sausage digits)	Back and hip pain
Eye Risk	Higher risk of chronic uveitis	Lower, but still requires monitoring

Symptoms to watch for in adolescents 

In older children and teenagers, the condition may manifest as pain in the heels, knees, or the base of the spine. This is often due to enthesitis, which is inflammation at the points where tendons or ligaments connect to the bone.¹⁴ Parents might notice that their teenager is struggling with sports or complaining of significant stiffness after sitting for long periods in school. 

Nail changes are particularly significant in this age group. Small pits in the nails, which may look like they have been pricked with a pin, are a strong indicator of psoriatic involvement. Because these changes can be subtle, they are often overlooked during a general physical examination but are a key focus for paediatric rheumatologists. 

Managing the condition in the UK 

The primary goal of managing juvenile psoriatic arthritis is to control inflammation quickly to prevent long term joint damage and to allow for normal growth and development. In line with NICE guidance, a “stepped” approach to treatment is usually followed: 

Non-steroidal Anti-inflammatory Drugs (NSAIDs)

Used initially to manage pain and swelling.

Methotrexate

Often the first-line disease-modifying drug (DMARD) used if NSAIDs are not enough to control the inflammation.

Biologic Therapies

If the condition remains active despite methotrexate, biologics such as Etanercept or Adalimumab may be prescribed. These are highly effective at treating both the joint inflammation and the skin symptoms.

In addition to medication, children and adolescents receive support from a multidisciplinary team, including physiotherapists to maintain joint function and ophthalmologists to monitor for silent eye inflammation (uveitis). 

Conclusion 

Psoriatic arthritis can start at any point during childhood or adolescence, often presenting in two distinct age peaks. While the lack of a skin rash in the early stages can make diagnosis complex, clinical features like dactylitis and nail changes are vital indicators. With early intervention and a tailored treatment plan from a paediatric rheumatology team, the majority of young people can achieve good disease control and maintain an active lifestyle. If you experience severe, sudden, or worsening symptoms, call 999 immediately.